Literature DB >> 18579025

Sleep disorders in Parkinson's disease.

Cynthia L Comella1.   

Abstract

Sleep disorders in Parkinson's disease (PD) are frequent and have numerous etiologies. Both nighttime sleep disturbances and daytime sleepiness can occur. The key to effective treatment is appropriate diagnosis. A careful interview of the patient and his or her bed partner provides direction for additional evaluations. Referral to a sleep specialist for quantitative studies is necessary to evaluate for rapid eye movement (REM) sleep behavior disorder, sleep apnea, periodic limb movements, and other sleep disorders. Excessive daytime sleepiness may be attributed to interrupted nighttime sleep or daytime medications (particularly the dopamine agonists) or it may be intrinsic to PD. When the diagnosis is established, treatment is directed toward the primary sleep disturbance. Fragmented sleep due to recurrence of PD symptoms may improve with the use of long-acting preparations of carbidopa/levodopa. Sleep apnea is treated using continuous positive airway pressure, and REM sleep behavior disorder may improve using pharmacologic interventions, although controlled trials are lacking. Restless legs syndrome and periodic limb movements during sleep are treated with direct dopaminergic agonists at bedtime. Excessive daytime sleepiness related to the use of direct dopaminergic agonists may improve with dosage reduction or discontinuation. Stimulants such as modafinil may provide modest benefit.

Entities:  

Year:  2008        PMID: 18579025     DOI: 10.1007/s11940-008-0023-z

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.598


  57 in total

1.  Methylphenidate improves fatigue scores in Parkinson disease: a randomized controlled trial.

Authors:  Dan A Mendonça; Krishe Menezes; Mandar S Jog
Journal:  Mov Disord       Date:  2007-10-31       Impact factor: 10.338

Review 2.  Rapid eye movement sleep parasomnias.

Authors:  Carlos H Schenck; Mark W Mahowald
Journal:  Neurol Clin       Date:  2005-11       Impact factor: 3.806

3.  Effect of exogenous melatonin on sleep and motor dysfunction in Parkinson's disease. A randomized, double blind, placebo-controlled study.

Authors:  Camila Andrade Mendes Medeiros; Pedro Felipe Carvalhedo de Bruin; Lívia Ariane Lopes; Maria Cecília Magalhães; Maria de Lourdes Seabra; Veralice Meireles Sales de Bruin
Journal:  J Neurol       Date:  2007-04-03       Impact factor: 4.849

Review 4.  Sleep disturbances and excessive daytime sleepiness in Parkinson disease: an overview.

Authors:  C L Comella
Journal:  J Neural Transm Suppl       Date:  2006

5.  Randomized trial of modafinil for treating subjective daytime sleepiness in patients with Parkinson's disease.

Authors:  Charles H Adler; John N Caviness; Joseph G Hentz; Marlene Lind; Judy Tiede
Journal:  Mov Disord       Date:  2003-03       Impact factor: 10.338

6.  Efficacy of cabergoline in long-term use: results of three observational studies in 1,500 patients with Parkinson's disease.

Authors:  H K Baas; P Schueler
Journal:  Eur Neurol       Date:  2001       Impact factor: 1.710

7.  A new method for measuring daytime sleepiness: the Epworth sleepiness scale.

Authors:  M W Johns
Journal:  Sleep       Date:  1991-12       Impact factor: 5.849

8.  Primary and secondary features of Parkinson's disease improve with strategic exposure to bright light: a case series study.

Authors:  Gregory L Willis; E John D Turner
Journal:  Chronobiol Int       Date:  2007       Impact factor: 2.877

Review 9.  Sleep disorders in Parkinson's disease: epidemiology and management.

Authors:  Mark Stacy
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

10.  Hypocretin (orexin) cell loss in Parkinson's disease.

Authors:  Thomas C Thannickal; Yuan-Yang Lai; Jerome M Siegel
Journal:  Brain       Date:  2007-05-09       Impact factor: 13.501

View more
  4 in total

1.  The Impact of Daily Sleep Hours on the Health of Korean Middle-Aged Women.

Authors:  Chang Ho Ha; Minyong Lee
Journal:  Community Ment Health J       Date:  2017-03-14

Review 2.  Gene therapy: a viable therapeutic strategy for Parkinson's disease?

Authors:  Alexander L Berry; Thomas Foltynie
Journal:  J Neurol       Date:  2010-10-21       Impact factor: 4.849

Review 3.  Imaging the aetiology of sleep disorders in dementia and Parkinson's disease.

Authors:  Nicola Pavese
Journal:  Curr Neurol Neurosci Rep       Date:  2014-12       Impact factor: 5.081

Review 4.  Current understanding of the molecular mechanisms in Parkinson's disease: Targets for potential treatments.

Authors:  Panchanan Maiti; Jayeeta Manna; Gary L Dunbar
Journal:  Transl Neurodegener       Date:  2017-10-25       Impact factor: 8.014

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.